NCT03228043 2024-11-14
Apatinib for Resectable Colorectal Cancer
Nanchong Central Hospital
Phase NA Withdrawn
Clinical Trials
15 trialsNCT04715633 2024-07-09
PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer
Sun Yat-sen University
Phase 2 Active not recruiting
NCT04073615 2024-05-02
A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)
Elevar Therapeutics
Phase 1 Terminated
NCT03743428 2023-06-29
BABST-C
Shenzhen People's Hospital
Phase NA Suspended
NCT04446091 2020-06-24
A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)
Zhejiang Cancer Hospital
Phase 1/2 Unknown
NCT03397199 2020-04-15
Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT03912857 2019-04-16
Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT03271255 2019-01-23
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
Shenzhen People's Hospital
Phase 2 Unknown
NCT03412994 2018-01-29
Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer
The Second People's Hospital of Yibin
Phase 2 Unknown
NCT03403452 2018-01-18
Apatinib in the Treatment of Metastatic Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT03377842 2017-12-19
Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer
Sichuan Provincial People's Hospital
Phase 2 Unknown
NCT03210064 2017-07-06
Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients
Hubei Cancer Hospital
Phase 2 Unknown
NCT03132025 2017-04-27
Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer
Harbin Medical University
Phase 2 Unknown
NCT02829385 2016-07-12
Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients
LanZhou University
Phase 2 Unknown
NCT01531777 2015-04-03
Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed